Key result
Immunosuppressive therapy with prednisolone and azathioprine improved LVEF from 17% to 52% within 3 months in a 17-year-old with hypertrophic cardiomyopathy and virus-negative myocarditis.
Why the study?
Does immunosuppressive treatment improve cardiac function and symptoms in a patient with hypertrophic cardiomyopathy transitioning to a dilated phenotype due to active myocarditis?
Case Report (n=1)
No
Does immunosuppressive treatment improve cardiac function and symptoms in a patient with hypertrophic cardiomyopathy transitioning to a dilated phenotype due to active myocarditis?
Answers are grounded in this paper and cite their sources.
External stress triggered by myocarditis can induce a reversible transition from a hypertrophic to a dilated cardiomyopathy phenotype, highlighting the diagnostic value of endomyocardial biopsy in unexplained heart failure.
We report the case of a 17-year-old female patient with known hypertrophic cardiomyopathy and a Wolff-Parkinson-White syndrome. She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fraction. Clinically, she complained about atypical chest pain, arrhythmic episodes with presyncopal events, and dyspnea (NYHA III) during the last 6 months. Non-invasive and invasive examinations including magnetic resonance imaging, electrophysiological examinations, and angiography did not lead to a conclusive diagnosis. Therefore, endomyocardial biopsies (EMBs) were taken to investigate whether a specific myocardial disease caused the impairment of the left ventricular function. EMB analysis resulted in the diagnosis of a virus-negative, active myocarditis. Based on this diagnosis, an immunosuppressive treatment with prednisolone and azathioprine was started, which led to an improvement of cardiac function and symptoms within 3 months after initiating therapy. In conclusion, we show that external stress triggered by myocarditis can induce a reversible transition from a hypertrophic cardiomyopathy to a dilated cardiomyopathy phenotype. This case strongly underlines the need for a thorough and invasive examination of heart failure of unknown causes, including EMB investigations as recommend by the actual ESC position statement.
No takes yet. Share an insight, caveat, or question.
Spillmann et al. (2015) conducted a case report in Hypertrophic cardiomyopathy transitioning to dilated cardiomyopathy due to virus-negative active myocarditis (n=1). Prednisolone and azathioprine was evaluated on Left ventricular ejection fraction (LVEF). Immunosuppressive therapy with prednisolone and azathioprine improved LVEF from 17% to 52% within 3 months in a 17-year-old with hypertrophic cardiomyopathy and virus-negative myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: